Care Management Solutions Market Key Companies Profile, Applications and Trends By 2023

The upsurge in the global geriatric population is also a key market driver. With the growth in the geriatric population, the burden of chronic diseases on healthcare is rising which requires proper management of healthcare costs and quality of care. Augmenting need to curb towering healthcare costs is one of the prime factors driving the growth of the global care management solutions market. Healthcare spending invariably grows faster than GDP and care management is an effective solution to reduce healthcare costs. The rise in multiple chronic diseases among the global population has added fuel to the growth of the market. Multiple chronic conditions (MCC) has now become a major medical and healthcare challenge which will further increase the burden of chronic illnesses among the population.

Global Care Management Solutions Market to be healthy and reach a significant valuation over the coming years. Care management comprises a set of activities aimed at improving patient care and assisting healthcare professionals in managing health conditions better. Care management solutions are deployed to enhance the experience of care, improve the health of populations and to reduce per capita costs of healthcare. With care management solutions, various processes can be automated such as adding patients to healthcare programs, sending reminders, scheduling appointments, assigning patients to care teams. In addition, care management solutions facilitate streamlining of processes of different healthcare departments. The global care management solutions market has been expanding on account of the high adoption of care management solutions among healthcare institutions.  

MCC patients suffer suboptimal health conditions and incur rising healthcare costs which necessitates an action-oriented framework to improve the quality of healthcare and life for individuals with MCC. The rise in multiple chronic diseases among the global population has added fuel to the growth of the market. The governments in numerous countries have endeavored to promote patient-centric healthcare and to promote healthcare IT which is furthering the growth of the market. However, lack of interoperability, high cost of deployment, lack of awareness and high incidences of healthcare data breaches are expected to constrain the growth of the global care management solutions market.

Competitive Landscape

The notable players operating in the global care management solutions market include AthenaHealth, Epic Systems Corporation, Cerner Corporation, Koninklijke Philips N.V., Allscripts Healthcare Solutions, EXL Healthcare, Cognizant Technology Solutions, HealthSmart Holdings, Casenet LLC, and Medecision.

Care Management Solutions Market Segmentation

The global care management solutions market has been segmented based on component, application, delivery method, and end user. By component, the market has been segmented into software and services. By application, the market has been segmented into diseases management, case management, utilization management, EMR management, and others. By the delivery method, the market has been segmented into web, cloud, and on-premise. By end-user, the market has been segmented into payers, providers, and others.

Care Management Solutions Market Regional Analysis

Regionally, the global care management solution market has been segmented into North America, Europe, Asia Pacific, and the Middle East & Africa.

America

      North America

• US
• Canada

      South America

Europe

      Western Europe

• Germany
• UK
• France
• Italy
• Spain

       Rest Of Western Europe

       Eastern Europe

Asia

• Japan
• China
• India
• Australia
• Republic Of Korea
• Rest Of Asia Pacific

Middle East & Africa

• United Arab Emirates
• Saudi Arabia
• Oman
• Kuwait
• Qatar
• Rest Of Middle East & Africa

Brows More Research Reports at:

Neuromodulation Devices Market Trends, Share | Size Analysis, 2023

Cardiopulmonary Resuscitation Market Trends, Size | Share Analysis, 2023

Cervical Dystonia Market Trends Analysis, Share | Size, Forecast To 2023

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact:

Akash Anand

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

Aphakia Market Dynamics, Outlook And Segmentation | Forecast to 2023

Aphakia Market Highlights

Changing lifestyle and increasing geriatric population have increased the probability of causing aphakia. Additionally, increasing need for the cost-effective treatment and increasing per capita income have fuelled the market growth. However, limited treatment options and high cost of the surgery may affect the growth of the market over the assessment period, negatively. 

The Global Aphakia Market is expected to grow at a CAGR of  9.2% during the forecast period 2017-2023. Aphakia is the absence or dislocation of lenses. Increasing prevalence of diabetes & other diseases, rising demand for the better treatment, and increasing number of ophthalmic surgeries drives the growth of the market. According to World Health Organization, in 2014, 285 million people were visually impaired across the globe and about 24.4 million American aged over 40 and half of the people who are over 75 have cataracts problem. Furthermore, in 2014, glaucoma affected over 2.7 million Americans of age 40 and older.

Aphakia Market Regional Analysis

The Americas commands the major share of the market owing to the large patient population, strong government support for research & development, growing prevalence of diabetes and aphakia and huge geriatric population.

Europe holds the second position in the global aphakia market followed by Asia Pacific.  The growth of the European market is majorly attributed to the increasing geriatric population, government support, and well-developed healthcare sector.

Asia Pacific is the fastest growing aphakia market. Japan, China, and India are the key contributor to the market growth due to rapidly growing economy, increasing healthcare expenditure, and huge population base. The UAE, Saudi Arabia, and Kuwait are expected to drive the Middle East & African market. The Middle East & Africa holds the least share of the global market due to limited availability of medical facilities and poor economic condition in African region.

Aphakia Market Segmentation

The global aphakia market is segmented on the basis of types, causes, treatment, and end user.

On the basis of type, the market is segmented into primary and secondary.

On the basis of cause, the market is categorized into congenital aphakia, surgical aphakia, acquired aphakia, and others. The acquired aphakia is further segmented into traumatic extrusion, posterior dislocation, couching, and other.

On the basis of treatment, the market is segmented into spectacles, contact lenses, intraocular lens implantation, refractive surgery, and others. The spectacles are sub-segmented into +10D, +3-4D, and other. The refractive surgery is further segmented into keratophakia, epikeratophakia, and hyperopic lasik.

On the basis of end user, the market is segmented into hospitals, ophthalmic clinics, and others.

Aphakia Market Key Players

Some of key the players in the market are Johnson & Johnson Services, Inc. (US), Ophtec BV (Netherland), Alcon Laboratories, Inc. (Switzerland‎), Bausch & Lomb (US), Carl Zeiss AG (Germany), Rayner Company (US), Bohus BioTech AB (Sweden), CooperVision, Inc. (US), Lifecore Biomedical, LLC (US), Aetna Inc. (US), Ciba Vision (Switzerland), and Menicon (Singapore).

Brows More Healthcare Related Research Reports

Medical Billing Market Size, Trends | Growth Analysis, 2023

Cholesterol Management Devices Market Size, Growth | Share Analysis, 2023

Artificial Insemination Market Size Analysis, Share | Industry Trends, 2025

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

+1 646 845 9312

Email: salesteam@marketresearchfuture.com

EMEA Beauty Devices Market Growth, Sales, Cost and Profit Till 2021

EMEA Beauty Devices Market Share, Trends And Growth Analysis By Product (Hair Care, Skin Care And Oral Care), By Application (Domestic Purpose, Commercial Purpose, And Others), By End Users (Professional And Personalized) - Forecast Till 2021

EMEA Beauty Devices Market Drivers and Restraints:

Increasing prevalence of skin and hair related issues owing to the alarming rise in pollution and extended exposure to ultraviolet radiations is inducing high demand for beauty devices that project fast results. The incorporation of advanced technology for introduction of highly effective beauty devices that can be controlled remotely through smartphones and emphasis on adoption of technologically advanced beauty devices are propelling the growth of the EMEA beauty devices market.

With the launch of affordable beauty devices in the market, the reach of these devices in the developing regions has increased. Hence, increasing disposable income in emerging economies and rising middle-class population are impacting positively on the expansion of the EMEA beauty devices market. Rise in prevalence of dermatological conditions and inclination towards home-based skin care solutions are likely to propel the growth of the EMEA beauty devices market. However, increasing awareness regarding the side-effects caused by using beauty devices and availability of alternative products that are comparatively cheaper are likely to pose a threat for the growth of the EMEA beauty devices market during the forecast period of 2017-2021.

EMEA Beauty Devices Market Overview:

Market Research Future (MRFR) has published a detailed report stating that the EMEA beauty devices market is anticipated to expand at a noteworthy CAGR of 7.4% during the forecast period of 2017-2021. Increasing pollution and exposure to UV rays are causing various skin and hair-related issues. Owing to the high demand for devices that provide quick beauty solutions, various beauty device manufacturers are integrating advanced technology with traditional beauty enhancing methods to develop highly efficient beauty devices.

EMEA Beauty Devices Market Segmentation:

The EMEA beauty devices market has been segmented on the basis of product type, application, and end-user. Based on product type, the EMEA beauty devices market has been segmented into hair care, skin care, oral care, and others. Hair care segment has been sub-segmented into hair removal devices, hair growth devices, hair styling devices, and others. The skin care segment has been sub-segmented into light/LED and photorejuvenation therapy devices, cellulite reduction devices, acne removal devices, and others

Based on application, the beauty devices market has been segmented into domestic purpose, commercial purpose, and others. Based on end-user, the beauty devices market has been segmented into professional and personalized. 

EMEA Beauty Devices Market Regional Analysis:

Geographically, the EMEA beauty devices market has been segmented into two major regions such as the Middle East and Africa and Europe. The Europe region is projecting dominance over the EMEA beauty devices market. The rapid incorporation of technologically advanced beauty devices for personal as well as professional use and increasing investment on easy-to-use and highly effective beauty devices are primarily fueling the growth of the beauty devices market in the Europe region. The beauty devices market in the Middle East and Africa region is majorly driven by increasing awareness regarding the benefits of beauty devices and easy market penetration of these devices through e-commerce platforms in this region.

EMEA Beauty Devices Industry Updates:

In September 2018, Foreo, a Swedish multi-national beauty brand, has launched a smallest AI-enabled smart cleaning device named the Luna Fofo. It enables personalized skincare accessible at the touch of a button.

In August 2018, Clarisonic, a skin care and beauty devices company, has launched the next generation devices that can be connected via Bluetooth to the mobile phone. The newly launched Mia Smart and Mia Prima are highly versatile and customizable smart devices by Clarisonic.

EMEA Beauty Devices Market Key Players:

Some of the leading players that are profiled by MRFR in the report on the EMEA beauty devices market are Nu Skin Enterprises Inc., L’Oréal Group, Tria Beauty Inc., Carol Cole Company, H.zone, and Koninklijke Philips N.V.

Brows More Healthcare Related Research Reports

Healthcare Information Governance Solution Market Report 2027 | MRFR

Filters and Particle Monitoring Market Trends, Size | Growth Analysis, 2023

Wearable Tracking Devices Market Trends, Growth | Size Analysis, 2023

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

 MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

 Contact:

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

Central Pontine Myelinolysis Market Insights, Key Players, Investment Feasibility By 2023

Central Pontine Myelinolysis Market Information: By Diagnosis (Magnetic Resonance Imaging (MRI), Computerized Tomography (CT), Electroencephalography, Others) By Treatment (Vitamin Supplementation, Electrolyte Mainainence, others)) By End Users - Global Forecast till 2023

Central Pontine Myelinolysis Market Highlights:

These neurological symptoms are manifested into nausea and vomiting, disturbed consciousness, gait changes, confusion, headache, seizures etc. Serious progressive neurological symptoms are, progressive development of spastic tetraparesis, pseudobulbar palsy etc. The diagnosis segment of central pontine myelinolysis especially the Magnetic Resonance Imaging (MRI) and Computed Tomography (CT) is growing fast. MRI is the test of choice with its high specificity and correct diagnosis capabilities. The market restraints are poor cure rates of central pontine myelinolysis, treatment, high cost of treatment etc.

Central pontine myelinolysis (CPM), also known as osmotic demyelination syndrome or central pontine demyelination, is a neurological disorder caused by severe damage of the myelin sheath of nerve cells. The drivers for central pontine myelinolysis market are increasing risk factors and cases of liver disease, liver transplant, alcoholism, severe burns, malnutrition, anorexia, severe electrolyte disorders, AIDS, hyperemesis gravidarum, anorexia nervosa, hematopoietic stem cell transplantation, Wernicke encephalopathy etc. CPM mostly affects the pons area of the brain and is characterized by acute paralysis, difficulty swallowing (dysphagia), difficulty speaking (dysarthria), and other neurological symptoms.

Global Central pontine myelinolysis Fujifilm Holdings Corporation, GE Healthcare, Siemens Healthcare GmbH, Philips Healthcare (Koninklijke Philips N.V.), Shimadzu Corporation, Toshiba Medical Systems Corporation, Carestream Health, Hitachi Medical Corporation and others.

Central Pontine Myelinolysis Market Segmentation

The global central pontine myelinolysis market has been segmented on the basis of diagnosis, treatment, and end users.

Based on diagnosis, the market has been segmented as Magnetic Resonance Imaging (MRI), Computerized Tomography (CT), electroencephalography and others.

Based on treatment, the market has been segmented as vitamin supplementation, electrolyte maintenance and others.

Based on the end users, the market has been segmented as hospitals & clinics, academic and research and others.

Central Pontine Myelinolysis Market Regional Analysis

The Americas account for a significant market share owing to extensive use of medications and high expenditure on the health care. Additionally, the fastest uptake of new drugs in the US drives the central pontine myelinolysis market. Also, concentration of major research companies in the developed countries of this region is adding fuel to the market growth. The large expenditure on the US healthcare accounting to 16% of GDP also cruises the sale of central pontine myelinolysis treatment.

Europe is the second largest market in the world due to high income and healthcare penetration. Europe is led by nations such as Germany and France. UK is expected to be the fastest growing market.

Asia Pacific region is expected to grow rapidly and China and India are likely to lead this market due to fast growing healthcare sector during the forecast period.

Gulf nations such as Saudi Arabia and the UAE are estimated to drive the Middle East & African market. The African region is expected to witness a moderate growth owing to poor economic and political conditions and poor healthcare development.

Brows More Healthcare Related Research Reports

Americas Diabetes Pen Market Trends, Share and Size Analysis, 2021

Test Strip Market Size, Growth and Share Analysis, 2021 | MRFR

Medical Ventilator Market Trends, Share | Size Analysis, 2023

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. 

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions. 

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members. 

Contact

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

Antihistamine Drugs Industry Insights, Segmentation and Investment Till 2023

Antihistamine Drugs Market share, growth and trends analysis By Type (Sedating, Non-Sedating), By Route of Administration (Oral Route, Parenteral Route, Rectal Route), By Indication (Allergy, Urticaria, Dermatitis, and others), End User (Hospitals, Clinics, Pharmaceutical Companies and others) - Global Forecast Till 2023

Antihistamine Drugs Market Highlights

The global antihistamine drugs market is expected to grow at a CAGR of 9.8% during the forecast period and is estimated to reach USD 280 million by 2023. Taste the market data and market information presented through more than 120 market data tables and figures spread over 200 pages of the project report. Avail the in-depth table of content TOC & market synopsis on “Antihistamine drugs market research report–Global forecast till 2023.

The Global Antihistamine Drugs Market is growing continuously and is expected to grow at a CAGR of 9.8% from 2017 to 2023. Antihistamines are commonly used for the treatment of allergies across the globe. Food and pet allergies are prevalent in various parts of the world. Therefore, the global antihistamine drugs market is expected to grow at a significant rate due to an increase in prevalence of allergic conditions and other diseases, and demand for new drugs for the treatment of these diseases.

Antihistamine Drugs Market Regional Analysis

The global antihistamine drugs market consists of four regions: the Americas, Europe, Asia Pacific, and the Middle East & Africa.

The Americas dominate the global antihistamine drugs market. It comprises of two regions namely North America and South America. North America in the largest market owing to development of new antihistamine drugs by major market players for the treatment of allergies.

In Europe, rising awareness about sedating and non-sedating antihistamine drugs and their side effects as well as precautionary awareness drives this market. Furthermore, increasing prevalence of allergy rhinitis is found in European nations which further propels the market growth.

Asia Pacific is the fastest growing and potential market for antihistamine drugs, whose growth is attributed to the rising awareness about allergic conditions and availability of medications for its treatment.

The Middle East & Africa is expected witness steady growth owing to the rising demand for drugs and healthcare resources in this region.

Major players in antihistamine drugs market

Some of the key players in the global market are Johnson & Johnson Consumer Inc. (U.S.), Sanofi (France), Bayer AG (Germany), Pfizer (U.S.), CVS pharmacy (U.S.), Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. (U.S.), and Prestige Brands Holdings, Inc. (U.S.)

Antihistamine Drugs Market Segmentation

The global antihistamine drugs market is segmented on the basis of types which includes sedating and non-sedating antihistamines. Sedating antihistamines are further sub-segmented into brompheniramine, chlorpheniramine, diphenhydramine, doxylamine, carbinoxamine and others. Non-sedating antihistamines are further sub-segmented into fexofenadine, loratadine, loratadine odt, and others.

 On the basis of route of administration, the market is segmented into oral route, parenteral route and rectal route. Parenteral route segmented is further sub-segmented into intramuscular, subcutaneous and intravenous route.

On the basis of indication, the market is segmented into allergy, urticaria, dermatitis, and others. And on the basis of end users, the market is segmented into hospitals, clinics, pharmaceutical companies and others.

Brows More Healthcare Related Research Reports

Intraoperative Neurophysiological Monitoring Market Size, Applications | Trends Analysis, 2027

Healthcare IoT Security Market Applications, Share | Size Analysis 2025

Ultra-Low Temperature Freezers Market by Type, Size, Growth and Analysis – 2024 | MRFR

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact

Market Research Future

+1 646 845 9312

Email: akash.anand@marketresearchfuture.com

Image Guided Radiotherapy Market Future Outlook, Emerging Trends | Forecast to 2023

Market Research Future Published a Half-Cooked Research Report on Image Guided Radiotherapy Market Research Report.

At the same time, the treatment allows scientists in the Centre for Cancer Imaging (ICR’s) to push boundaries with the very latest in single and combined imaging technologies to visualize tumors precisely and study their behavior, physiology, and growth. All these commutatively add up to deliver effective outcomes in the treatment of various types of cancer such as skin cancer, lung cancer, lung cancer, and others.

Market Research Future (MRFR) in its recently published study report asserts that the global image guided radiotherapy market will register a CAGR of 15.8% during 2017 – 2023, accruing pervasively by 2023. Image Guided Radiotherapy or IGRT is a type of conformal radiotherapy involving the use of different scans and X-rays to treat a specific area of cancer growth. Image-guided radiation therapy integrated with a technique called intensity-modulated radiotherapy (IMRT), enables to shape the radiation beam to the outline of tumors in real time, even as they move in the body. This treatment targets tumors with pinpoint accuracy, and minimize the side-effects caused by damage to healthy tissue.

Therefore, the image-guided radiotherapy is considered as a proven, effective cancer treatment which is allowing its market to accrue vastly. Certainly, technological advancements transpired in the medical science and biotechnology is a major driving force that escalates the market on the global platform, improving the outlook for cancer treatments and sufficiently controlling the spread of the diseases.

Additionally, factors such as increasing population, heredity reasons and genetic mutations (abnormal changes), exposures to harmful radiation along with the increasing per capita health care expenditures are substantiating the market growth. Besides, increasing governmental initiatives are supporting the market growth, spreading the awareness among people.

Conversely, the high cost of the treatment & devices, along with the side effects of the therapy and long approval time for the clinical trials are obstructing the market growth, slowing the market growth over the forecasted period. However, unavailability of comprehensive treatments especially in the developing regions is expected to provide the ample scope to the market to evolve further, prompting substantial investments for R&D to bring more novelty and betterments in the image-guided radiotherapy.

Cancer cases are increasing rapidly, worldwide, and the changing lifestyle is the main culprit.  Improving economic conditions are playing the main role in increasing the purchasing power of people, increasing access to the modern lifestyle. Addictions such as tobacco and alcoholism are again some of the dominant risk factor helping the cancerous cells and tumors to develop.

Global Image Guided Radiotherapy Market Geographical Analysis

The North American region dominates the global image guided radiotherapy market.  The market growth is majorly supported by the radiotherapy market in the US which is growing due to the large patient pool and substantial healthcare expenditures.

Furthermore, the increasing prevalence of types of cancer and thyroid fuelled by the consequences of the wrong lifestyle fosters the market growth in the region. Moreover, factors such as technological advancement and well-spread awareness among people towards the benefits of this therapy support the market growth.

The image guided radiotherapy market in the European region rapidly emerging as another lucrative market owing to the increasing number of cancer patients in the region. Furthermore, the proliferation of advanced treatment facilities alongside the availability of skilled medical professionals, and the government support for research & development drives the market in the region.

The Asia Pacific region accounts for another promising market for the image-guided radiotherapy. Factors substantiating the market growth include the increasing prevalence of cancer, spreading awareness among people about cancer, and the availability of new treatment methods. Proliferating markets in China and India majorly contribute to the market growth in the region.

The Image Guided Radiotherapy market in the Middle East and Africa region is expected to witness a slow growth due to the lack of awareness of the chronic diseases and the limited treatment facilities in these regions.

Global Image Guided Radiotherapy Market Segmentation

By Types:  Soft-Tissue Imaging, Lung MRI, Simplifying Cardiac MRI, Simplifying MRI-Conditional Implant Scans, and Silent MRI Scanning.

By Technologies: Radiation-Based (electronic portal imaging devices (EPID), cone beam CT, Fan beam, and others.), and Non-Radiation Based Systems (ultrasound-based systems, camera-based or optical tracking systems, MRI-guided IGRT, and others.), among others.

By Devices: X-ray computed tomography (digital X-ray, computed tomography (CT), conventional CT, optical tracking, cone beam, MVCT, and others.), magnetic resonance imaging (MRI), positron emission tomography, and others.

By End-users: Hospitals, Smart Cancer Centers, and Research Institutes among others. 

By Regions:  APAC, North America, Europe, and the Rest-of-the-World.

Global Image Guided Radiotherapy Market – Competitive Landscape

The market is fiercely competitive due to the presence of numerous large & small players, having the international presence. The global market for image guided radiotherapy appears intensely competitive with the several large and small players forming a competitive edge in the market incorporating strategic partnership, collaboration, acquisition, expansion, and technology launch.  Significant investments are transpired in the field to bring innovations in the therapy and clinical trials.

Key Players:

Some of the imminent players in the image guided radiotherapy market are General Electric Company (US), ViewRay (US), Hitachi, Ltd. (Japan), Koninklijke Philips N.V. (Netherland), Siemens AG (Germany), Varian Medical Systems, Inc. (US), Toshiba Corporation (Japan), Vision RT Ltd. (UK), XinRay Systems (US), C-RAD (Sweden), and Scranton Gillette Communications (US).

Industry/ Innovation/Related News:

ViewRay, Inc. (US), a medical technology company announced the unveiling of its new, MRIdian MR-Image guided radiation therapy in the Acibadem Maslak Hospital in Istanbul, Turkey for the Next Generation Cancer Care.

ViewRay's MRIdian® Linac is the world's first system to combine MRI guidance and linear accelerator radiation delivery.  These treatments mark the first in Turkey.

MRIdian MRI-guided radiotherapy represents the latest advancement in the field of radiation oncology that allows clinical improvements in visualization and precision daily plan adaptation, providing the tools to deliver higher and potentially more effective radiation doses.

Brows More Healthcare Related Research Reports

Clinical Reference Laboratory Market Share Analysis, Size | Industry Trends, 2027

Hydrocephalus Market Research Report –Global Forecast to 2023 | MRFR

Facial Injectable Market Trends Analysis, Share | Size and Applications, 2023

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

 MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

 Contact:

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

Lichen Sclerosus Treatment Market Profile, Sales, Cost and Capacity By 2023

Lichen Sclerosus Treatment Market Highlights

Prevalence of skin diseases is increasing across the globe.  People are unaware of most of the rare skin diseases, which is one of the driving factors of the market. Moreover, lichen sclerosus treatment market is driven by growing prevalence of this disease in both developed and developing countries. Additionally, increasing geriatric population with skin disease, which remain untreated for a long period of time boost the market growth.

The global lichen sclerosus treatment market is expected to grow at a CAGR of 7.8% during the forecast period and is estimated to reach USD 150 million by 2023. Lichen sclerosus is underdiagnosed condition of the anogenital region. It is often painful and itchy and may cause sexual and urinary dysfunction.

Lichen Sclerosus Treatment Market Regional Analysis

The global lichen sclerosus treatment market consists of four regions: the Americas, Europe, Asia Pacific, and the Middle East & Africa.

The Americas dominates the global lichen sclerosus treatment market. It comprises of two regions namely North America and South America. North America is the largest market owing to rising prevalence of skin diseases in the American counties and increasing geriatric population with skin diseases. According to the American Academy of Dermatology, 50% of Americans over age 65 have skin disease.

In the Europe, extensive demand for skin care and topical products to treat skin diseases drives the market growth. Moreover, increasing investment in research & development in developing new treatment methods for skin related diseases add fuel to the growth of the market.  

Asia Pacific is the fastest growing and potential market for the lichen sclerosus treatment owing to increasing number of dermatology clinics and rising prevalence of lichen sclerosus in the developing countries. Rising prevalence of vulva’s lichen sclerosus in women act as a risk factor for vulvar cancer also drives the growth of this market.  

The Middle East & Africa is expected witness steady growth due to rising demand for primary healthcare services such as diagnosis and medical devices.

Major Players in Lichen Sclerosus Treatment Market

Some of the key players in the global market are AstraZeneca plc, Bristol-Myers Squibb Company, GlaxoSmithKline plc, Johnson & Johnson Services, Inc., Merck & Co., Inc., Pfizer Inc., Sandoz AG (Novartis AG), Sanofi S.A., Valeant Pharmaceuticals, and Zylera Pharmaceuticals.

Lichen Sclerosus Treatment Market Segmentation

The global lichen sclerosus treatment market is segmented on the basis of type of treatment, which includes drug therapy, and surgery. He drug therapy is further segmented into corticosteroid, immune modulating drugs, retinoid like agents, and others. The surgery is further segmented into laser surgery, circumcision, and others. On the basis of mode of administration, the market is segmented into oral, topical, IV (Intravenous), and others. The oral administration is further segmented into tablets, capsule and others. The topical administration is further segmented into creams, ointment, and others. On the basis of end user, the market is segmented into hospitals, dermatology clinics, pharmacies, and others.

Brows More Healthcare Related Research Reports

Ticagrelor Market Size, Growth and Share Analysis, 2023 | MRFR

Arterial Blood Collection Market Trends, Application | Size Analysis, 2023

Stroke Post Processing Software Market by Type, Growth and Forecast – 2024 | MRFR

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact

Market Research Future

+1 646 845 9312

Email: akash.anand@marketresearchfuture.com